Cargando…

Disease X and other unknowns

Detalles Bibliográficos
Autor principal:	Honigsbaum, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136972/ https://www.ncbi.nlm.nih.gov/pubmed/30983581 http://dx.doi.org/10.1016/S0140-6736(19)30803-7

Ejemplares similares

In search of sick parrots: Karl Friedrich Meyer, disease detective
por: Honigsbaum, Mark
Publicado: (2014)

Antibiotic antagonist: the curious career of René Dubos
por: Honigsbaum, Mark
Publicado: (2016)

Hongjie Yu: monitoring avian influenza in China
por: Honigsbaum, Mark
Publicado: (2009)

Ebola: epidemic echoes and the chronicle of a tragedy foretold
por: Honigsbaum, Mark
Publicado: (2014)

Revisiting the 1957 and 1968 influenza pandemics
por: Honigsbaum, Mark
Publicado: (2020)

Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers
por: Honigsbaum, Mark, et al.
Publicado: (2020)

Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism
por: Hoskisson, Paul A., et al.
Publicado: (2020)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Deaths due to Unknown Foodborne Agents
por: Frenzen, Paul D.
Publicado: (2004)

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

Restless Legs Syndrome: Known Knowns and Known Unknowns
por: Antelmi, Elena, et al.
Publicado: (2022)

Intermittent Hypoxia and Respiratory Plasticity: The Good, the Bad, and the Unknown
por: Sheel, Andrew William
Publicado: (2023)

New era: prospects for managing cancer of unknown primary
por: Li, Yize, et al.
Publicado: (2023)

One Health, “Disease X” & the challenge of “Unknown” Unknowns
por: Chatterjee, Pranab, et al.
Publicado: (2021)

Beyond the Unknown: A Broad Framing for Preparedness for Emerging Infectious Threats
por: Christofferson, Rebecca C., et al.
Publicado: (2022)

Severe acute hepatitis of unknown origin in children: Clinical issues of concern
por: Fu, Hai-Jing, et al.
Publicado: (2023)

Severe acute hepatitis in children with unknown aetiology, etiology analysis and the next action
por: Gao, Yuan, et al.
Publicado: (2022)

Symptom tracking in endometriosis using digital technologies: Knowns, unknowns, and future prospects
por: Edgley, Katherine, et al.
Publicado: (2023)

Disease‐X: Accounting for the unknown
por: Banerjee, Sumitaksha, et al.
Publicado: (2023)

Cardiovascular Disease: The Other Face of Diabetes
por: Vlasakakis, G, et al.
Publicado: (2013)

Unknown Risk on the Farm: Does Agricultural Use of Ionophores Contribute to the Burden of Antimicrobial Resistance?
por: Wong, Alex
Publicado: (2019)

A Healthy Fear of the Unknown: Perspectives on the Interpretation of Parameter Fits from Computational Models in Neuroscience
por: Nassar, Matthew R., et al.
Publicado: (2013)

Complexity of Infectious Diseases Compared With Other Medical Subspecialties
por: Grundy, Brian, et al.
Publicado: (2023)

Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
por: D'Amico, Emanuele, et al.
Publicado: (2021)

The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients?
por: de Buhr, Nicole, et al.
Publicado: (2021)

Task Force for a rapid response to an outbreak of severe acute hepatitis of unknown aetiology in children in Portugal in 2022
por: Grau-Pujol, Berta, et al.
Publicado: (2023)

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
por: Bhattacharya, Deepta
Publicado: (2022)

Invited Perspective: Phthalates and Blood Pressure: the Unknowns of Dietary Factors
por: Arenas, Ivan A.
Publicado: (2021)

BACE1 role in Alzheimer's disease and other dementias: from the theory to the practice
por: Cervellati, Carlo, et al.
Publicado: (2021)

Navigating facilitated regulatory pathways during a disease X pandemic
por: Simpson, Shmona, et al.
Publicado: (2020)

How Important Is Diabetes as a Risk Factor for Cardiovascular and Other Diseases in Older Adults?
por: Kengne, Andre Pascal, et al.
Publicado: (2006)

Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine
por: Yuzhalin, Arseniy E, et al.
Publicado: (2012)

Introduction: microbes, networks, knowledge—disease ecology and emerging infectious diseases in time of COVID-19
por: Honigsbaum, Mark, et al.
Publicado: (2020)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
por: Tayyaba Rehan, Syeda, et al.
Publicado: (2022)

Coordination of autophagy with other cellular activities
por: Wang, Yan, et al.
Publicado: (2013)

Pharma partnering: other people’s science
por: Hofmann, Christian
Publicado: (2017)

Quantifying resilience of humans and other animals
por: Scheffer, Marten, et al.
Publicado: (2018)

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID‐19 pandemic, now and in the future
por: Mok, Vincent C.T., et al.
Publicado: (2020)

Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases
por: Carbone, Francis R.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jf99ptci3a91avqip95tgdpe6